Skip to content

WHWK WHWK Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$163.1M+169%
Gilead Sciences logo
Gilead SciencesGILD
$166M-34.1%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$1.19M+4.9%
OS Therapies logo
OS TherapiesOSTX
$1.05M-76.5%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$228.35M
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$2.18M

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's stock issuance proceeds?
WHWK (WHWK) reported stock issuance proceeds of $0 in Q1 2026.
How has WHWK's stock issuance proceeds changed year-over-year?
WHWK's stock issuance proceeds decreased by 100.0% year-over-year, from $21K to $0.
What is the long-term trend for WHWK's stock issuance proceeds?
Over 2 years (2021 to 2024), WHWK's stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $155M to $0.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.